Best of BGICC 2025: 17th Breast-Gynecological International Cancer Conference

Breast Gynecological and Immunooncology International Cancer Conference (BGICC) 2025 is took place on January 23-24, 2025, at the Hilton Cairo Heliopolis.

With 5,000 participants from over 50 countries, BGICC has grown to become a global hub for knowledge-sharing and collaboration in cancer care. Founded to advance research in breast and gynecological oncology, the conference provides an unparalleled opportunity for specialists to exchange ideas, discuss cutting-edge research, and shape the future of oncology.

Here are a few not to miss highlights from BGICC 2025 picked by OncoDaily:

BGICC:

“Capturing Every Moment at BGICC 2025!

Day 1 of the 17th Breast Gynecological and Immunooncology International Cancer Conference (BGICC) is in full swing, and our cameras are rolling to bring you the highlights of this incredible event!

From inspiring keynote speeches to groundbreaking sessions and vibrant networking moments, we’re documenting it all. Stay tuned for daily updates, behind-the-scenes glimpses, and snapshots of the brightest minds in oncology from around the globe.

Date: 23 January 2025
Venue: Hilton Cairo Heliopolis

Let’s celebrate innovation, collaboration, and progress in the fight against cancer – one shot at a time.”

Julie Gralow:

“Congratulations to Prof. Hesham El Ghazaly and team on an excellent 17th annual Breast, Gynecologic, and Immunologic International Cancer Conference in Cairo, Egypt.”

Gevorg Tamamyan:

“Breast Gynecological & Immunooncology International Cancer Conference-BGICC is a GREAT success! Several thousand participants, outstanding program and speakers, excellent organization! It is a great pleasure and honor for the OncoDaily team to be present here and to cover this amazing event! My sincere congratulations to Prof. Hesham ElGhazaly and the whole team behind it! It is really outstanding, no words.”

SPCC:

“The 17th edition of the Breast Gynecological & Immunooncology International Cancer Conference-BGICC was superbly organised by Prof. Hesham ElGhazaly and his team.

Speakers from MENA and the rest of the world discussed the latest updates in surgery, radiation oncology, and medical oncology, from screening to diagnosis and treatment.

Debates about areas of uncertainty and consensus sessions animated the busy working days.

A great dinner and a musical show by the famous singer Maï Farouk closed this top level meeting.

Discover More.”

Amalya Sargsyan:

“BGICC 2025 kicked off with 5000 attendees in Cairo, Egypt! Prof. Giuseppe Curigliano set the stage with an inspiring session on DESTINY-Breast06, highlighting the potential of T-DXd in HER2-low/ultralow HR+ mBC.

OncoDaily is here – stay tuned for live podcasts and onsite interviews!”

Ossama Shaheen:

“During my speech at the high-level delegation meeting on the sideline of BGICC, to announc the formation of the regional alliance of the Oncology Accociations, witnessed by the leaders of Chinese, American, and Russian Oncology accociations. We emphasized that fostering regional partnerships and sharing expertise among Arab nations is a critical step in tackling the increasing challenges posed by cancer. Collaboration between health institutions and research centers plays a key role in accelerating technology transfer, implementing global best practices, and strengthening the capabilities of local medical professionals.”

Mahmoud Ashraf:

“Praise and thanks to God it was a beautiful day we thank God for his bounty and generosity
We thank Professor Sarah Hassan for giving us the opportunity to lecture and attend the conference and for the organization and arrangement and the details of the preparation to know what she went through during the past days Thank you to her for everything

I thank the best doctors I knew at work and in our life abroad from the first moment I met them in order that I met them Dr. Shayma Mostafa and Dr. Aya Mohamed and Dr. Reham Mamdouh and I appreciate very much their encouragement and education and we will never forget their favor.

And I am proud to be with my work friends with this greatness of science and beautiful soul God bless us always and I am grateful to them for everything Jomana osama, Fatma Naser Arafa, Dalia Hussein, Gehad Mohamed, Basant Essam.

And our dear friend
Ahmed El Sayed & Dr. Ahmed Khattab

Thanks to our unity, our laboratory, and our great center for everything Molecular Genomics Unit – MASRI

And I would like to express my joy and thanks to all the people that we met because of the conference before and after or in the trainings or through the unit of trainees companies researchers students and all wonderful people Thank you all for your personality and for your knowledge and your efforts and thanks to all the people to you the last lecture with us I had the honor to know you and good luck always and excuse me if I forgot anyone
Thank you all

Finally, with all due respect and appreciation to our professor and leader, Professor Hisham El-Ghazali, director of the Ain Shams Medical Research Center and the great leader of the BGICC conference. And the picture that I wait every year and thank God its greatness increased with the presence of Prof Loay God bless you in your knowledge.

Thanks to all and there are respectable people I met but unfortunately I cant find them I hope to see you in good health always

Every year and you are good and God willing we meet fine every year and every day.”

Shushan Hovsepyan:

“OncoDaily is in Cairo!

The 17th BGICC has officially started with more than 5,000 participants from across the globe.

Follow OncoDaily for the latest updates and key moments from this incredible event.”

Ahmed Abdelkader:

“Proud to Announce My Attendance at the 17th BGICC 2025!

I am delighted to share that I will be attending the Breast Gynecological and Immunooncology International Cancer Conference (BGICC 2025)—the largest and most prestigious cancer conference in Africa and the Middle East.

Where: Hilton Heliopolis Hotel, Cairo, Egypt
When: January 23rd–24th, 2025

This incredible event will feature rich content lectures, hands-on workshops, and in-depth courses focused on advancing cancer research and treatment.

Under the theme “Illumination and Creation,” BGICC 2025 is set to bring together top professionals and innovators in oncology to drive impactful change.

I’m looking forward to gaining valuable insights, building connections, and contributing to the future of cancer care.”

Egyptian Society of Breast Imaging – EGSBI:

“The first day of the BGICC Conference 2025 concluded successfully with a remarkable lineup of sessions and hands-on workshops!

Here’s a recap of Day 1:

Scientific Sessions:

• Prof. Rasha Kamal: Welcome Note
• Prof. Jessica Leunge:BI-RADS 6th Edition – What Has Changed?
• Prof. Jennifer Harvey: Breast Calcifications Made Easy
• Prof. Niketa Chotai: AI in Breast Imaging: Will It Replace the Radiologist?
• Prof. Tanya Chawla: Pitfalls in Gynecologic Imaging
• Prof. Merit Elmaadawy: Fat Necrosis or Something Else? Navigating the Challenges in Interpretation
• Prof. Rasha Kamal: Patterns of Contrast Uptake in Different Breast Pathologies
• Panel Discussion: Pregnancy-Associated Breast Cancer – Imaging Protocols and Guide to Management, moderated by Prof. Aml Hegazy

Workshops:

• Pelvic Imaging Workshop: Led by A. Prof. Heba Hassan 
  supported by Siemens Healthineers .
• Breast Intervention Workshop:
  Led by, Prof. Aml Hegazy, Dr. Lamiaa AdelandProf Merit Elmaadawy.
  supported by Siemens Healthineers .
• Test Your Skills Against AI:
  Led by Dr. Yasmin nada supported by Fujifilm Global Technology.
• Test Your Mammography and CEM Reading Skills:
  Led by Dr. Sherihan FakhryandDr. Eman Faker
  supported by GE HealthCare

We’re looking forward to more exciting sessions and interactions on Day 2!”

Viacheslav Burmistrov:

“This is my second year attending BGICC in Cairo, and once again, I find the congress incredibly valuable and insightful for oncologists in the MENA region.

The level of speakers is outstanding, and the quality of scientific discussions and insights is truly impressive. I’m delighted to see how MSD contributes to this remarkable event through numerous scientific sessions and activities.

A heartfelt thanks to my dear MSD colleagues in Egypt for their incredible hospitality and drive, and a special shukran to the medical team for their exceptional professionalism and leadership in improving patients’ lives.”

Mohamed El-Sisi:

“I am honored to participate in BGICC WITH MY E-POSTER about Herceptin biosimilar KANJINTI in treatment of HER2 positive breast cancer.”

Salsabil Tarek:

“I had the privilege of attending the 17th BGICC Breast-Gynecological & Immuno-oncology International Cancer Conference this year, where I gained valuable insights into the latest research and advancements in the treatment of cancers, especially breast and gynecological cancers.
The conference provided an incredible opportunity to connect with leading experts in the field and exchange ideas on innovative treatments and best practices.”

Eman Naguib Khorshed:

“I’m extremely honored and privileged to be part of this prestigious event Breast Gynecological and Immunooncology International Cancer Conference-BGICC, sharing the knowledge and updates in breast cancer diagnosis and management among oncology and pathology experts.

Don’t miss the chance to join the multidisciplinary panel discussion, sponsored by Roche Middle East, to learn more about the best practices in breast cancer management for the best to our patients.”

Sana Al Sukhun:

“Had a great time at 17th BGIICC, and Oncothoracic international congress Ontic; sharing ideas during my talk and connecting with so many brilliant colleagues.
Huge thanks and congrats to Hesham ElGhazaly, Ola Khorshid,Hagar ElGhazawy, Nermean Mostafa and team for hosting such a fantastic event.”

Habiba Gamal:

“I had the incredible opportunity to attend the 17th Breast Gynecological & Immunooncology International Cancer Conference-BGICC and BioNetMasr Network Masr and wanted to express my gratitude to all the speakers who shared their knowledge and insights. Grateful for the opportunity to be part of such an enriching conference and to connect with brilliant minds in the field. Let’s continue advancing our understanding and treatment of cancer through collaborative efforts!”

Mary Nyangasi-Onyango:

“As I reflect upon the past one year at the WHO Global Breast Cancer Initiative I am overwhelmed by the facts..that this past year alone, 2.3million women have been diagnosed with breast cancer and 670,000 have lost their lives…literally every minute we lose a woman to this disease, the majority, about 70-80% are in low and middle income countries and nearly half of these are premature deaths before the age of 70years. The impact is devastating to families and society at large..

The global breast cancer initiative if implemented could save 2.5M lives by 2040 through mortality reduction. Indeed, the recent investment case by WHO EMR demonstrated a return of between 6.4-7.8 USD for each dollar spent on breast cancer early diagnosis and treatment and an economic loss of USD 408B by 2050 if the status quo persists.
This week hosted the World Economic Forum at Davos as well as the High-Level Dialogue on women’s cancer in Egypt convened by the Presidential Initiative for Women’s Health on the sidelines of the 17th Breast and Gynaecological Cancer International Conference BGICC2025.

I attended the later and it was great interacting with colleagues and friends. It’s amazing to see in Egypt how political goodwill can transform society.. already the key performance indicators are being achieved and with sustained efforts the country will be on track to achieve a 2.5% per year reduction in breast cancer mortality by 2040. This requires collaboration and bringing everyone on board to ensure access to care and universal health coverage is achieved. We urge all governments to adopt and implement the GBCI and save women, generations and build our economies.

The time for action is now..”

Nour Khalil Eltawy:

“Thrilled to have been part of BGICC 2025!

The sessions were packed with cutting-edge insights, innovative ideas, and discussions around the future of the industry. I’m grateful for the opportunity to learn, network, and collaborate with so many brilliant minds.

Events like these are a great reminder of the power of continuous learning and staying updated on the latest trends. Looking forward to applying the knowledge gained and staying connected with the amazing people I met!”

Abd El-Rahman Shaltout:

“It was a great opportunity to attend the 17th BGICC 2025 – the renowned Breast Gynecological & Immunooncology International Cancer Conference-BGICC, known as the largest and most prestigious cancer conference in Africa and the Middle East.

Exploring cutting-edge topics including:

– Next Generation Sequencing: Popular Applications In Clinical Medicine.
– Genomics In Action: Data Sharing, Innovation, And Value Creation.
– AI Everywhere Transforming Genomics From Lab To Market.”

Ahmed El Taie:

“Attending the 17th Breast Gynecological & Immunooncology International Cancer Conference-BGICC in Cairo has been an incredibly enriching experience!

This unique event gathered prominent figures from around the world, all united in the mission to advance the fight against cancer. The congress kicked off with an inspiring opening session featuring the Minister of Health, which set a powerful tone for the discussions that followed.

I am especially proud to be part of MSD significant contribution during this exceptional event, particularly during the Press Conference where we unveiled a pivotal regional study focused on Triple-Negative Breast Cancers (TNBCs). This research highlights the urgent need for innovative solutions and collaborative efforts within our community to enhance patient outcomes.”

Further Reading:

Introducing the Radiology Course at BGICC 2025

BGICC 2025: Hear from Global Oncology Leaders

How Egypt is closing the gap in breast cancer care: Dr. Hesham El-Ghazaly leads the conversation

The 17th Annual BGICC Conference Kicks Off in Cairo, Egypt with 5,000 Attendees

Scientific Insights from Prof. Hope Rugo: Advancements in Metastatic HER2+ Breast Cancer Therapy